Correlation Between Vigil Neuroscience and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vigil Neuroscience and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vigil Neuroscience and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vigil Neuroscience and Eliem Therapeutics, you can compare the effects of market volatilities on Vigil Neuroscience and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vigil Neuroscience with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vigil Neuroscience and Eliem Therapeutics.
Diversification Opportunities for Vigil Neuroscience and Eliem Therapeutics
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Vigil and Eliem is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Vigil Neuroscience and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Vigil Neuroscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vigil Neuroscience are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Vigil Neuroscience i.e., Vigil Neuroscience and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Vigil Neuroscience and Eliem Therapeutics
Given the investment horizon of 90 days Vigil Neuroscience is expected to generate 0.82 times more return on investment than Eliem Therapeutics. However, Vigil Neuroscience is 1.22 times less risky than Eliem Therapeutics. It trades about -0.11 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about -0.38 per unit of risk. If you would invest 358.00 in Vigil Neuroscience on August 25, 2024 and sell it today you would lose (39.00) from holding Vigil Neuroscience or give up 10.89% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vigil Neuroscience vs. Eliem Therapeutics
Performance |
| Timeline |
| Vigil Neuroscience |
| Eliem Therapeutics |
Vigil Neuroscience and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vigil Neuroscience and Eliem Therapeutics
The main advantage of trading using opposite Vigil Neuroscience and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vigil Neuroscience position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Vigil Neuroscience vs. Molecular Partners AG | Vigil Neuroscience vs. Pmv Pharmaceuticals | Vigil Neuroscience vs. Monte Rosa Therapeutics | Vigil Neuroscience vs. Entrada Therapeutics |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |